Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.
about
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinDiagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewAutoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueIdentification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritisCitrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisThe role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysisIncreased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR CohortA case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' allelesRadiographic estimation in seropositive and seronegative rheumatoid arthritisA systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisRheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestationsDiagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.Prognostic laboratory markers of joint damage in rheumatoid arthritis.A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French populationEULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritisAnti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritisA new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritisAutoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis.ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritisDiagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis.Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis.Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis.The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris
P2860
Q21195679-3547786F-1F7C-40F3-835A-D5ABA6005CDFQ24675281-D219610D-9F29-48FC-86F6-7512BBBD2963Q24806041-21FF090F-0F15-4AEC-9EEB-AD37AF53858DQ24813085-FB823EE8-B822-488F-B6E3-1F7C5E8827DDQ24816615-2F1ED050-5490-482C-B955-CB141F868A53Q26828418-A9D6B69C-3406-4E0C-9C96-B55860B4150EQ26999006-1FD6AFD5-4CC3-41BD-9DB0-F9D6DFD14C4DQ31038073-79823F36-7AE0-48B0-B0F1-C50D6F7CFECFQ33300467-185DDFB5-38C4-4D7C-A18A-841F32766096Q33873636-3B26E93C-AF09-4E28-840E-151826C9AE05Q34208191-53271E9F-EF67-4CEE-913E-C08032061934Q34244715-E53181A6-8EDF-498A-9B08-D1105F498CDCQ34348712-E944B6E0-ED12-4640-A05E-6D8987D897D8Q34635933-FD084009-8C98-4744-A99E-D2A84C5133E6Q34650192-49AE4B6E-B065-48F3-A8E3-E82DB854D80EQ34897056-7DA21FE5-FA06-45D5-AFB7-3AEE5B8C7735Q35136055-91062F7A-6FE9-4E1F-8CD1-062E358507D5Q35184666-0A5E45C5-EE59-4AF1-828B-EA42B22CB0EEQ35207886-7ED99171-7E48-4E20-B871-5BBCBDDFC1F6Q35553712-43F0799B-5C47-4497-B330-D276276A4CA0Q35554481-85B442E1-3A4D-41A6-B877-D7D501825BC8Q35554508-2B7C4231-52FA-49E3-B0B7-B53CB65ABBE3Q35554533-6A7A411A-05E8-496A-A1B7-BCA9D7F3BDB3Q35554665-8DF6B18A-8E3C-48B3-8C24-D5C16A62BB88Q35554739-875FA745-6620-4636-861F-3940D7F2D75AQ35555179-2B35B696-5234-4A1B-BF47-5C7DBF53055AQ35555382-52849C92-1413-4394-9881-9F86E7E4372EQ35638360-D5105CAD-C466-46CB-9DFA-FEDC789007ADQ35760039-3820FE91-3BD7-4AFD-892A-A4F24198AC58Q35760091-4C7BC1A2-318E-4A20-B824-315E6ADC002EQ35784822-ABD81CFD-6F4A-4033-8891-84F33C1A56ABQ35868959-9BCB819D-0C05-4285-8CF0-AFF975C5F09DQ35934700-6AA9A161-987A-4C06-BEE0-794A6257DAA9Q36183852-54681001-A28D-4258-9BFB-D360D70ABA1CQ36184783-298BDD6D-7885-4FA8-8F27-A90D8A53D643Q36226393-34B0B6F4-1259-477E-BBC2-FF7247E70FD5Q36245951-A3212467-FCE9-4062-892B-D3560130E185Q36395509-BB3871E1-7CD0-47C1-AC4F-D3C09F3C384FQ36475622-C5EB607F-4965-4A70-A562-124FBC3F908CQ36733774-3BBBC92F-C2C8-4543-B72E-7402135CA113
P2860
Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Autoantibodies can be prognost ...... in early rheumatoid arthritis.
@en
type
label
Autoantibodies can be prognost ...... in early rheumatoid arthritis.
@en
prefLabel
Autoantibodies can be prognost ...... in early rheumatoid arthritis.
@en
P2093
P2860
P50
P356
P1476
Autoantibodies can be prognost ...... in early rheumatoid arthritis
@en
P2093
S Machácek
S Růzicková
V Pesáková
P2860
P304
P356
10.1136/ARD.62.5.427
P407
P577
2003-05-01T00:00:00Z